Exogene Company
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.
Investors
Technology:
Artificial Intelligence, Biotechnology, Life Science, Pharmaceutical
Industry:
AI, Early Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2019-11-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
7
Total Funding:
2105637
Last Funding Date:
2022-04-25
Last Funding Type:
Pre-Seed
Register and Claim Ownership